Essex Financial Services Inc. decreased its position in Clorox Co. (NYSE:CLX) by 4.1% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 2,742 shares of the company’s stock after selling 118 shares during the period. Essex Financial Services Inc.’s holdings in Clorox were worth $379,000 at the end of the most recent quarter.
A number of other hedge funds also recently modified their holdings of CLX. Invictus RG bought a new stake in shares of Clorox during the first quarter worth about $110,000. Checchi Capital Advisers LLC boosted its stake in shares of Clorox by 1.0% in the second quarter. Checchi Capital Advisers LLC now owns 820 shares of the company’s stock worth $113,000 after buying an additional 8 shares during the period. Mutual of Omaha Bank Wealth Management boosted its stake in shares of Clorox by 14.6% in the second quarter. Mutual of Omaha Bank Wealth Management now owns 2,350 shares of the company’s stock worth $226,000 after buying an additional 300 shares during the period. Paragon Capital Management Ltd bought a new stake in shares of Clorox during the second quarter worth about $232,000. Finally, Sand Hill Global Advisors LLC boosted its stake in shares of Clorox by 12.7% in the first quarter. Sand Hill Global Advisors LLC now owns 2,142 shares of the company’s stock worth $270,000 after buying an additional 241 shares during the period. 70.20% of the stock is currently owned by institutional investors and hedge funds.
Clorox Co. (NYSE:CLX) traded down 0.27% during trading on Tuesday, reaching $121.80. The company had a trading volume of 721,440 shares. The company has a market capitalization of $15.77 billion, a PE ratio of 24.76 and a beta of 0.30. Clorox Co. has a one year low of $119.23 and a one year high of $140.47. The firm’s 50 day moving average is $124.81 and its 200 day moving average is $129.64.
Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, August 3rd. The company reported $1.26 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.28 by $0.02. Clorox had a net margin of 11.25% and a return on equity of 296.91%. The business earned $1.60 billion during the quarter, compared to analysts’ expectations of $1.58 billion. During the same quarter in the previous year, the firm earned $1.44 earnings per share. Clorox’s revenue was up 2.8% on a year-over-year basis. On average, equities research analysts predict that Clorox Co. will post $5.49 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 14th. Stockholders of record on Wednesday, October 26th will be given a $0.80 dividend. The ex-dividend date is Monday, October 24th. This represents a $3.20 annualized dividend and a dividend yield of 2.63%. Clorox’s payout ratio is 64.91%.
A number of brokerages recently issued reports on CLX. Goldman Sachs Group Inc. reissued a “neutral” rating and set a $131.00 price objective (up previously from $125.00) on shares of Clorox in a report on Friday, July 15th. Zacks Investment Research upgraded Clorox from a “sell” rating to a “hold” rating in a research note on Tuesday, July 12th. B. Riley restated a “neutral” rating and issued a $109.00 target price on shares of Clorox in a research note on Thursday, August 4th. Citigroup Inc. upped their target price on Clorox from $134.00 to $144.00 and gave the stock a “neutral” rating in a research note on Monday, August 8th. Finally, Atlantic Securities upgraded Clorox from a “hold” rating to a “buy” rating and set a $144.00 target price on the stock in a research note on Friday, September 16th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $127.80.
In other news, COO Dawn C. Willoughby sold 10,617 shares of the business’s stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $131.01, for a total value of $1,390,933.17. Following the transaction, the chief operating officer now directly owns 20,353 shares in the company, valued at $2,666,446.53. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Nikolaos A. Vlahos sold 925 shares of the business’s stock in a transaction dated Wednesday, August 10th. The shares were sold at an average price of $133.07, for a total value of $123,089.75. The disclosure for this sale can be found here. 0.74% of the stock is owned by insiders.
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).
Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.